日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Hsa-miR-1276 in peripheral blood mononuclear cells as a potential biomarker for rheumatoid arthritis

外周血单核细胞中的hsa-miR-1276作为类风湿性关节炎的潜在生物标志物

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-025-02004-3
Zhang, Nan; Hou, Jie; Yue, Chenglong; Chen, Yuzuo; Su, Zhenzhen
关节炎
单核细胞
细胞生物学
发表日期：2026
文献求助 收藏

SF3B4 regulates proliferation and apoptosis in hepatocellular carcinoma via alternative splicing and interaction with TRIM28 and SETD5.

SF3B4 通过选择性剪接和与 TRIM28 和 SETD5 的相互作用来调节肝细胞癌的增殖和凋亡

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06420-7
Huang HanFei, Fang Yuan, Li ZhiTao, Qu SiMing, Yuan Bo, Gan Kai, Yue ChengLong, Li HaiJing, Wen YuBo, Zeng Zhong
细胞生物学
Apoptosis
凋亡
发表日期：2025
文献求助 收藏

Single-cell RNA-seq reveals novel interaction between muscle satellite cells and fibro-adipogenic progenitors mediated with FGF7 signalling

单细胞 RNA 测序揭示了由 FGF7 信号介导的肌肉卫星细胞与纤维脂肪形成祖细胞之间的新相互作用

期刊:Journal of Cachexia Sarcopenia and Muscle
影响因子:9.4
doi:10.1002/jcsm.13484
Lu Ma, Yingying Meng, Yalong An, Peiyuan Han, Chen Zhang, Yongqi Yue, Chenglong Wen, Xin'e Shi, Jianjun Jin, Gongshe Yang, Xiao Li
细胞生物学
其它细胞
发表日期：2024
文献求助 收藏

MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation

MALT1是胶质母细胞瘤的潜在治疗靶点，并在EGFR诱导的NF-κB激活中发挥关键作用。

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.15383
Liu, Xuejiao; Yue, Chenglong; Shi, Lin; Liu, Guanzheng; Cao, Qiyu; Shan, Qianqian; Wang, Yifeng; Chen, Xiangyu; Li, Huan; Wang, Jie; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong
NF-κB
MALT1
EGF
EGFR
细胞生物学
发表日期：2020
文献求助 收藏

FoxR2 promotes glioma proliferation by suppression of the p27 pathway.

FoxR2 通过抑制 p27 通路促进胶质瘤增殖

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.17447
Liu Xuejiao, Liu Ning, Yue Chenglong, Wang Dacheng, Qi Zhenglei, Tu Yiming, Zhuang Guokun, Zhou Di, Gao Shangfeng, Niu Mingshan, Yu Rutong
信号转导
胶质瘤
发表日期：2017
文献求助 收藏

CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways

CRM1/XPO1与胶质瘤的临床结果相关，可通过干扰多个核心通路成为治疗靶点。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-016-0338-2
Liu, Xuejiao; Chong, Yulong; Tu, Yiming; Liu, Ning; Yue, Chenglong; Qi, Zhenglei; Liu, Huize; Yao, Yao; Liu, Hongmei; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong
信号转导
胶质瘤
发表日期：2016
文献求助 收藏